SCHEMBL5823374

SCHEMBL5823374

Clc1cccc(-c2ncsc2-c2ccnc(NC3CCCC3)n2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 2/20 0.53
EIF2AK2 P19525 1/20 0.46
MAPK10 P53779 4/20 0.45
MAPK8 P45983 3/20 0.45
MAPK9 P45984 3/20 0.45
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
IKBKB O14920 2/20 0.44
MAPK1 P28482 4/20 0.44
PLK1 P53350 1/20 0.43
CCNA2 P20248 4/20 0.42
CDK2 P24941 4/20 0.42
MAPK3 P27361 3/20 0.42
RET P07949 1/20 0.41
CDK1 P06493 2/20 0.41
CCNB1 P14635 2/20 0.41
CDC7 O00311 1/20 0.41
PLK4 O00444 1/20 0.41
JAK2 O60674 1/20 0.41
CCNB2 O95067 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5819449 0.99 ADORA1 (0.52) ADORA1EIF2AK2MAPK10MAPK8MAPK9
SCHEMBL5814670 0.96 ADORA1 (0.47) ADORA1EIF2AK2MAPK10MAPK8MAPK9
SCHEMBL5816324 0.88 BRAF (0.49) EIF2AK2MAPK10MAPK1CCNA2CDK2
SCHEMBL5813771 0.88 MAPK14 (0.50) ADORA1EIF2AK2MAPK10MAPK1CCNA2
SCHEMBL5811808 0.87 BRAF (0.48) MAPK10MAPK8MAPK9MAPK1CCNA2
SCHEMBL5818867 0.87 MAPK14 (0.49) ADORA1EIF2AK2MAPK10CCNA2CDK2
SCHEMBL5814307 0.85 MAPK9 (0.46) MAPK9MAPK1CCNA2CDK2MAPK3
SCHEMBL1030530 0.83 ADORA1 (0.59) ADORA1EIF2AK2MAPK10MAPK8MAPK9
SCHEMBL3619159 0.83 ADORA1 (0.59) ADORA1EIF2AK2MAPK10MAPK8MAPK9
SCHEMBL5813443 0.83 MAPK14 (0.45) MAPK10MAPK8MAPK9IKBKBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed